Wolverine Asset Management LLC Axsome Therapeutics, Inc. Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$50.63 - $73.5 $518,552 - $752,787	-10,242 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $62,675 - $91,294	-1,121 Reduced 9.87%	10,242 $579,000
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $753,480 - $983,126	11,363 New	11,363 $925,000
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $486,922 - $611,610	-7,125 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $194,592 - $385,088	3,902 Added 121.07%	7,125 $586,000
Q1 2020 May 13, 2020	BUY	$41.2 - $101.31 $132,787 - $326,522	3,223 New	3,223 $189,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.77B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.